Showing 581 - 600 results of 1,150 for search '(( b ((large decrease) OR (larger decrease)) ) OR ( ct ((values decrease) OR (largest decrease)) ))', query time: 0.43s Refine Results
  1. 581

    Table 1_Interaction with IGF1 overrides ANXA2-mediated anti-inflammatory functions of IGFBP5 in vivo.docx by Yan Fan (575147)

    Published 2025
    “…IGFBP5 decreased in ALI mice’s blood, while its supplement exacerbated inflammation. …”
  2. 582

    Table 2_Interaction with IGF1 overrides ANXA2-mediated anti-inflammatory functions of IGFBP5 in vivo.xlsx by Yan Fan (575147)

    Published 2025
    “…IGFBP5 decreased in ALI mice’s blood, while its supplement exacerbated inflammation. …”
  3. 583
  4. 584
  5. 585
  6. 586
  7. 587
  8. 588
  9. 589
  10. 590

    Characterising the i-band variability of YSOs over six orders of magnitude in timescale (dataset) by D Sergison (21909218)

    Published 2025
    “…We present an i-band photometric study of over 800 young stellar objects in the OB association Cep OB3b, which samples timescales from 1 minute to ten years. …”
  11. 591
  12. 592
  13. 593
  14. 594
  15. 595
  16. 596
  17. 597
  18. 598

    Image 6_Tumor-associated bacteria activate PRDX1-driven glycolysis to promote immune evasion and PD-1 antibody resistance in hepatocellular carcinoma.jpeg by Heng Zhang (320479)

    Published 2025
    “…In vivo, bacterial infection decreased the antitumor efficacy of PD-1 blockade by 43% (tumor volume vs. control; p = 0.008), an effect that was reversed upon PRDX1 inhibition.…”
  19. 599

    Image 5_Tumor-associated bacteria activate PRDX1-driven glycolysis to promote immune evasion and PD-1 antibody resistance in hepatocellular carcinoma.jpeg by Heng Zhang (320479)

    Published 2025
    “…In vivo, bacterial infection decreased the antitumor efficacy of PD-1 blockade by 43% (tumor volume vs. control; p = 0.008), an effect that was reversed upon PRDX1 inhibition.…”
  20. 600

    Image 1_Tumor-associated bacteria activate PRDX1-driven glycolysis to promote immune evasion and PD-1 antibody resistance in hepatocellular carcinoma.jpeg by Heng Zhang (320479)

    Published 2025
    “…In vivo, bacterial infection decreased the antitumor efficacy of PD-1 blockade by 43% (tumor volume vs. control; p = 0.008), an effect that was reversed upon PRDX1 inhibition.…”